NEUROLOGICAL BIOMARKERS Market Key Players: Abbott Laboratories, Myriad RBM, Proteome Sciences, Thermo Fisher Scientific, Athena Diagnostics, Immunarray Pvt. Ltd., Quanterix Corporation

A fresh report titled “NEUROLOGICAL BIOMARKERS Market” has been presented by KD market insights. It evaluates the key market trends, advantages, and factors that are pushing the overall growth of the market. The report also analyzes the different segments along with major geographies that have more demand for NEUROLOGICAL BIOMARKERS Market. The competition analysis is also a major part of the report.

The neurological biomarkers market for Alzheimers disease generated a revenue of $2,636.7 million in 2017, registering a CAGR of 11.1% from 2018 to 2025. On the other hand, neurological biomarkers market for Parkinsons disease is expected to reach $2,457.4 million by 2025, registering a CAGR of 8.0%.

Alzheimers is included under dementia-associated conditions, and patients suffering from Alzheimers face short-term memory loss, cognitive issues, and issues regarding behavior. In addition, Alzheimer is considered to be the most common form of dementia, and is known to account for the majority of the total dementia cases across the globe.

Request for Sample @ https://www.kdmarketinsights.com/sample/4107

On the contrary, Parkinsons disease is the second most common neurodegenerative disorder across the globe. Patients suffering from Parkinsons disease face progressive deterioration of motor function that occurs over a period of time due to the loss of brain cells that produce dopamine. In-spite of being the second most common neurodegenerative disorder (after Alzheimers), the market for this disease is relatively small, as the definite cause and treatment is unknown. This has opened up new avenues for the use neurological biomarkers. The neurological biomarkers market for Alzheimers and Parkinsons diseases is studied across the U.S., EU5, rest of Europe, China, Asia-Pacific, and rest of the world (ROW).

KEY BENEFITS
- The study provides an in-depth analysis of the neurological biomarkers market, with current trends and future estimations regarding Alzheimers and Parkinsons.
- A quantitative analysis from 2017 to 2025 is discussed to enable the stakeholders to capitalize on the prevailing market opportunities.
- Strategies recorded by the key players are analyzed thoroughly to understand the competitive outlook of the market.
- Porter's Five Forces model is expected to interpret the bargaining power of suppliers & buyers, threat of new entrants & substitutes, and competition among the key players.

KEY MARKET SEGMENTS
By Region
- U.S.
- EU5
- Rest of Europe
- China
- Asia-Pacific
- Row

KEY MARKET PLAYERS
- Abbott Laboratories
- Myriad RBM
- Proteome Sciences
- Thermo Fisher Scientific
- Athena Diagnostics
- Immunarray Pvt. Ltd.
- Quanterix Corporation
- Diagenic ASA
- Psynova Neurotech
- Bio-Rad Laboratories

The other players in the value chain include (profiles not included in the report)

- Qiagen
- AbaStar MDx
- Acumen Pharmaceuticals
- Abiant
- Alseres Pharmaceuticals
- Athena Diagnostics
- Banyan Biomarkers
- ProteoSys AG

Browse Full Report With TOC@ https://www.kdmarketinsights.com/product/neurological-biomarkers-market-amr

Table of Content

CHAPTER 1: INTRODUCTION
1.1. Report description
1.2. Key benefits for stakeholders
1.3. Key market segments
1.4. Research methodology
1.4.1. Secondary research
1.4.2. Primary research
1.4.3. Analyst tools & models
1.4.4. Key assumptions
1.4.5. Key experts

CHAPTER 2: EXECUTIVE SUMMARY
2.1. CXO perspective

CHAPTER 3: MARKET OVERVIEW
3.1. Market definition and scope
3.2. Top winning strategies
3.3. Overall Diagnostic Market Size
3.3.1. Total diagnostic market size by diagnostic techniques
3.4. Incidence, Mortality, Diagnosis Rate, Prevalence Rate and Treatment Rate for Alzheimers And Parkinsons Disease
3.4.1. Incidence rate
3.4.2. Mortality
3.4.3. Diagnosis rate
3.4.4. Prevalence rate
3.4.5. Treatment rate
3.5. Porters five forces analysis
3.6. Market dynamics
3.6.1. Drivers
3.6.1.1. Increasing focus on developing cost-effective biomarker testing
3.6.1.2. Rising demand for non-invasive diagnostic techniques for Alzheimers and Parkinsons
3.6.1.3. Increase in the adoption of neurological biomarkers in clinical trials
3.6.2. Restraints
3.6.2.1. Stringent government regulations
3.6.2.2. Emerging ethical issues regarding early diagnosis of Alzheimers and Parkinsons
3.6.3. Opportunity
3.6.3.1. Rise in the demand for personalized medicine

CHAPTER 4: ALZHEIMER’S DISEASE BIOMARKERS MARKET, BY REGION
4.1. Overview
4.1.1. Market size and forecast
4.2. U.S.
4.2.1. Key market trends and opportunities
4.2.2. Market size and forecast
4.3. EU5
4.3.1. Key market trends and opportunities
4.3.2. Market size and forecast
4.4. Rest of Europe
4.4.1. Key market trends and opportunities
4.4.2. Market size and forecast
4.5. China
4.5.1. Key market trends and opportunities
4.5.2. Market size and forecast
4.6. Asia-Pacific
4.6.1. Key market trends and opportunities
4.6.2. Market size and forecast
4.7. Rest of World (ROW)
4.7.1. Key market trends and opportunities
4.7.2. Market size and forecast

CHAPTER 5: PARKINSONS DISEASE BIOMARKERS MARKET, BY REGION
5.1. Overview
5.1.1. Market size and forecast
5.2. U.S.
5.2.1. Key market trends and opportunities
5.2.2. Market size and forecast
5.3. EU5
5.3.1. Key market trends and opportunities
5.3.2. Market size and forecast
5.4. Rest of Europe
5.4.1. Key market trends and opportunities
5.4.2. Market size and forecast
5.5. China
5.5.1. Key market trends and opportunities
5.5.2. Key market trends and opportunities
5.5.3. Market size and forecast
5.6. Asia-Pacific
5.6.1. Key market trends and opportunities
5.6.2. Market size and forecast
5.7. ROW
5.7.1. Key market trends and opportunities
5.7.2. Market size and forecast
Continue…

Check for Discount @ https://www.kdmarketinsights.com/discount/4107

Contact Us
KD Market Insights
150 State Street, Albany,
New York, USA 12207
+1 (518) 300-1215
Email: sales@kdmarketinsights.com
Website: www.kdmarketinsights.com

About KD Market Insights
KD Market Insights offers a comprehensive database of syndicated research studies, customized reports, and consulting services. These reports are created to help in making smart, instant and crucial decisions based on extensive and in-depth quantitative information, supported by extensive analysis and industry insights.
Our dedicated in-house team ensures the reports satisfy the requirement of the client. We aim at providing value service to our clients. Our reports are backed by extensive industry coverage and is made sure to give importance to the specific needs of our clients. The main idea is to enable our clients to make an informed decision, by keeping them and ourselves up to date with the latest trends in the market.

This release was published on openPR.